以岭药业：2025年预盈12亿元—13亿元 同比扭亏

Core Viewpoint - Yiling Pharmaceutical (002603) expects a significant turnaround in its financial performance, projecting a net profit of 1.2 billion to 1.3 billion yuan for 2025, compared to a loss of 725 million yuan in the same period last year [1] Group 1: Financial Performance - The company anticipates a recovery in operating revenue, focusing on long-term development while expanding its market presence and enhancing internal management [1] - The management emphasizes a comprehensive budget management strategy and the establishment of a full-chain cost control system, which is expected to lead to improved quality and efficiency [1] - Profit margin levels are projected to increase significantly as a result of these strategic initiatives [1]